TYMP and neoplasm: CAP is converted to 5-FU via a multiorgan, three-step enzymatic pathway, and malignant tissues have higher concentrations of thymidine phosphorylase, which is involved in drug conversion, so 5-FU increases enrichment at tumor sites, and CAP exhibits better tumor suppressive activity in multiple PDX models (20).